ACB
ACHC icon

Aristotle Capital Boston’s Acadia Healthcare ACHC Stock Holding History

Aristotle Capital Boston’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2M Sell
521,667
-79,987
-13% -$1.45M 0.76% 61
2025
Q4 		$8.54M Sell
601,654
-61,999
-9% -$1.17M 0.47% 85
2025
Q3 		$16.4M Buy
663,653
+88,361
+15% +$1.97M 0.85% 49
2025
Q2 		$13.1M Sell
575,292
-43,099
-7% -$1.02M 0.66% 62
2025
Q1 		$18.7M Sell
618,391
-123,342
-17% -$4.7M 0.94% 40
2024
Q4 		$29.4M Sell
741,733
-84,529
-10% -$3.81M 1.09% 35
2024
Q3 		$52.4M Sell
826,262
-32,987
-4% -$2.38M 1.74% 11
2024
Q2 		$58M Sell
859,249
-46,819
-5% -$3.27M 1.95% 7
2024
Q1 		$71.8M Sell
906,068
-22,077
-2% -$1.81M 2.18% 3
2023
Q4 		$72.2M Sell
928,145
-40,767
-4% -$3.02M 2.21% 1
2023
Q3 		$68.1M Sell
968,912
-69,304
-7% -$5.18M 2.2% 3
2023
Q2 		$82.7M Buy
1,038,216
+8,455
+0.8% +$611K 2.48% 1
2023
Q1 		$74.4M Buy
1,029,761
+22,804
+2% +$1.78M 2.3% 1
2022
Q4 		$82.9M Sell
1,006,957
-25,224
-2% -$2.08M 2.62% 1
2022
Q3 		$80.7M Sell
1,032,181
-95,164
-8% -$7.61M 2.73% 1
2022
Q2 		$76.2M Sell
1,127,345
-93,970
-8% -$6.56M 2.27% 2
2022
Q1 		$80M Sell
1,221,315
-24,539
-2% -$1.43M 2.02% 5
2021
Q4 		$75.6M Sell
1,245,854
-42,976
-3% -$2.56M 1.77% 6
2021
Q3 		$82.2M Sell
1,288,830
-3,553
-0.3% -$224K 1.93% 4
2021
Q2 		$81.1M Sell
1,292,383
-77,510
-6% -$4.86M 1.86% 5
2021
Q1 		$78.3M Sell
1,369,893
-59,973
-4% -$3.25M 1.74% 5
2020
Q4 		$71.9M Sell
1,429,866
-81,722
-5% -$3.26M 1.7% 8
2020
Q3 		$44.6M Buy
1,511,588
+54,201
+4% +$1.57M 1.29% 21
2020
Q2 		$36.6M Buy
1,457,387
+137,345
+10% +$3.43M 1.11% 32
2020
Q1 		$24.2M Sell
1,320,042
-20,720
-2% -$593K 1.04% 34
2019
Q4 		$44.5M Buy
1,340,762
+27,559
+2% +$864K 1.23% 22
2019
Q3 		$40.8M Buy
1,313,203
+170,516
+15% +$5.19M 1.2% 24
2019
Q2 		$39.9M Buy
1,142,687
+53,511
+5% +$1.73M 1.25% 22
2019
Q1 		$31.9M Buy
1,089,176
+588,079
+117% +$16.7M 1.06% 31
2018
Q4 		$12.9M Buy
501,097
+84,769
+20% +$2.93M 1.06% 36
2018
Q3 		$14.7M Buy
416,328
+95,701
+30% +$3.81M 1.08% 39
2018
Q2 		$13.1M Sell
320,627
-214,360
-40% -$8.64M 1.04% 41
2018
Q1 		$21M Buy
534,987
+207,590
+63% +$7.61M 0.99% 41
2017
Q4 		$10.7M Buy
327,397
+180,385
+123% +$6.25M 0.78% 60
2017
Q3 		$7.02M Buy
147,012
+27,405
+23% +$1.34M 0.63% 75
2017
Q2 		$5.91M Buy
119,607
+47,651
+66% +$2.11M 0.66% 73
2017
Q1 		$3.14M Buy
71,956
+17,053
+31% +$692K 0.42% 93
2016
Q4 		$1.82M Buy
+54,903
New +$2.13M 0.25% 100

Other funds holding ACHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Aristotle Capital Boston's ACHC Position: Q1 2026 in Review

Aristotle Capital Boston reduced its Acadia Healthcare (ACHC) stake by 13% in Q1 2026, selling an estimated $1.45M and leaving 521,667 shares worth $12.2M. The position accounts for 0.76% of the portfolio, ranked #61.

Aristotle Capital Boston first reported a position in ACHC in Q4 2016 and has held it in 38 quarters since. The position peaked at $82.9M in Q4 2022. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Aristotle Capital Boston held 521,667 shares of Acadia Healthcare worth $12.2M as of Q1 2026.
  • Aristotle Capital Boston sold 79,987 Acadia Healthcare shares in Q1 2026, an estimated $1.45M.
  • Acadia Healthcare made up 0.76% of Aristotle Capital Boston's portfolio in Q1 2026, its #61 holding.
  • Aristotle Capital Boston first reported a position in Acadia Healthcare in Q4 2016 and has held it in 38 quarters since.
  • Aristotle Capital Boston's Acadia Healthcare position peaked at $82.9M in Q4 2022.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Aristotle Capital Boston's 13F filing for Q1 2026, filed 15 May 2026.